Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
ECOG 1308: A phase II trial of induction chemotherapy followed by cetuximab with low dose versus standard dose IMRT in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx (OP). 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) Marur, S., Lee, J., Cmelak, A., Zhao, W., Westra, W. H., Chung, C. H., Gillison, M. L., Gilbert, J., Bauman, J. E., Wagner, L. I., Ferris, R. L., Trevarthen, D. R., Colevas, A. D., Jahagirdar, B. N., Burtness, B. AMER SOC CLINICAL ONCOLOGY. 2012
View details for Web of Science ID 000318009800120